April 24, 2014
|
You are subscribed to the Cosmetic Surgery Times Trends.
|
|
Mainstream media has gotten really good at knowing how to grab our attention with their stream of creative headlines that make you go hmm… On one hand, we’ve heard some version of all of this before; on the other, inquiring minds want to know: Is there any validity with these claims? » More
|
A Swiss research team has shown that engineered cartilage may be a future treatment possibility. That’s according to a recent study published in The Lancet that reports the successful growth and grafting of engineered cartilage in five rhinoplasty patients. » More
|
ADVERTISEMENT
Botulinum toxin injections: Cosmetic & Therapeutic treatment options
Botulinum toxin have a variety of medical uses, including smoothing out frown lines and treating pain. Articles, video, tools, and CME to help you stay up-to-date on the latest medical advances involving neurotoxins. Read More.
|
Is the US market for aesthetic implants on the decline? Yes and no, according to the Decision Resources Group, who recently announced their Medtech 360 report, “US Markets for Nonbreast Aesthetic Implants 2014.” » More
|
|
ADVERTISEMENT
|
ADVERTISEMENT
|
We want to hear from you!
Have comments or questions about the eNewsletter? Contact Cosmetic Surgery Times Trends Aesthetics Editor Eliza Cabana at [email protected]
|
|
|
 |
 |
 |
 |
 |
 |
 |
Tina Alster, M.D. |
James Carraway, M.D |
Steven Fagien, M.D., F.A.C.S. |
David H. McDaniel, M.D. |
Patrick G. McMenamin, M.D. |
Joe Niamtu III, D.M.D., F.A.C.S. |
Jeffrey C. Popp, M.D., F.A.C.S. |
|
|